![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 32, 24560-24564, August 11, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the
Received for publication, May 15, 2000
Integrin receptor
The widely expressed integrin receptor family mediates many
cell-cell and cell-matrix interactions. Each receptor comprises a
heterodimeric, non-covalent complex of an The platelet integrin The affinity of some integrins depends upon Ca2+ (17-20).
Micromolar Ca2+ is required to stabilize the Against this background, we examined the effects of the
Ca2+ chelator, EGTA, on adhesion of platelets, of
Materials--
Human platelets were from fresh whole blood,
provided by the National Blood Service, Long Road, Cambridge, UK.
Platelets lacking Static Platelet Adhesion Assay--
96-well plates (Immulon 2, Dynex Technologies, Ashford, Middlesex, UK) were coated with 100 µl
per well of monomeric type I collagen or peptides GFOGER-GPP or
CRP at 10 µg/ml in 0.01 M acetic acid for
1 h at 20 °C. Platelet-rich plasma was prepared from fresh
whole blood after 2 spins for 1 min at 1200 × g. 10% (v/v) of ACD buffer (39 mM citric acid, 75 mM
tri-sodium citrate·2H2O, 135 mM
D-glucose, pH 4.5) and prostaglandin E1 (100 ng/ml final concentration) were added, and the platelet-rich plasma was
spun for 6 min at 700 × g. The platelet pellet was
resuspended in 6 ml of buffer (5.5 mM
D-glucose, 128 mM NaCl, 4.26 mM
Na2HPO4·2H2O, 7.46 mM
NaH2PO4·2H2O, 4.77 mM tri-sodium citrate·2H2O, 2.35 mM citric acid, 0.35% bovine serum albumin (BSA), pH 6.5).
Prostaglandin E1 was added as before, and the platelets
were spun for 6 min at 700 × g. Platelets were
resuspended to 2 × 108 platelets/ml in adhesion
buffer (0.05 M Tris-HCl, 0.14 M NaCl, 0.1%
BSA, pH 7.4) and treated as appropriate with MgCl2,
CaCl2, or EGTA and allowed to rest for 15 min at room
temperature. Ligand-coated wells were blocked by incubation with 200 µl of blocking buffer (0.05 M Tris-HCl, 0.14 M NaCl, 5% BSA, pH 7.4) for 30 min. The wells were washed
three times with 200 µl of adhesion buffer, then 50 µl of platelet
suspension (107 platelets) was added to each well and left
for 1 h. The wells were emptied and washed three times with 200 µl of adhesion buffer to remove non-adherent platelets.
Adherent platelets were lysed by incubation for 1 h with 150 µl per well of lysis buffer (0.07 M tri-sodium citrate,
0.3 M citric acid, 0.1% Triton X-100 (v/v), 5 mM p-nitrophenyl phosphate). The reaction was
terminated by the addition of 100 µl of 2 M NaOH to each
well. Adhesion was measured colorimetrically as the absorbance of the
p-nitrophenol product at 405 nm in a Maxline Emax
microplate reader (Molecular Devices Ltd., Crawley, UK). Values were
corrected for background by subtraction of readings from BSA-coated
wells. In agreement with others (35), the relationship between platelet
number and A405 was linear up to 3.0 (Fig. 1) in
our conditions, and in a typical experiment, adhesion to collagen I
resulted in A405 ~1 ± 0.3, which
corresponds to adhesion of ~20% of the cells applied. For clarity,
absorbance values were scaled so that platelet adhesion to collagen I
in the presence of 2 mM Mg2+ alone resulted in
A405 = 1, as we have done previously (14).
Integrin Calcium Concentration Calculations--
These were performed
using the program WinMAXC v2.05 (36) from Dr. Chris Patton at Stanford University.
Replication and Presentation of Data--
Data were obtained
from Glanzmann's platelets for two identical experiments using blood
from different donors. All other experiments were performed on at least
three separate occasions. Mean values ± S.D. from single
representative experiments are shown throughout, with each condition
tested in triplicate. Where error bars are absent, they were too small
to reproduce.
Platelet Adhesion via Integrin
When platelets from normal donors were preincubated with an RGD
mimetic, GR144053F, at the previously established maximal level for
blockade of
If the observed effects of EGTA were solely due to inhibition of
Preincubation with a monoclonal antibody specific for the integrin
To confirm the independence of the effect of EGTA from
Although EGTA chelates Ca2+, its inhibitory effect could be
due to the removal of other ions such as Zn2+ or
Co2+, possibly present at trace levels in the medium, which
might be essential for ligand binding. However, addition of micromolar Ca2+ to EGTA-inhibited platelets restored adhesive
function, confirming that Ca2+ is sufficient to support
adhesion in the presence of Mg2+ (Fig.
4). However, platelet adhesion to
collagen I and to GFOGER-GPP was inhibited in the presence of
millimolar Ca2+, in agreement with the work of others (24,
25). Over several different experiments, rescue of platelet adhesion
occurred in the estimated free Ca2+ concentration ranges
(36): 58-323 nM (collagen I) and 20-323 nM
(GFOGER-GPP), where 50% maximal adhesion occurred at a free Ca2+ concentration of 88 ± 28 or 110 ± 57 nM for collagen I and GFOGER-GPP, respectively (the latter
values are given as mean ± S.E. of five determinations).
It is not surprising that the amount of Ca2+ needed to
restore EGTA-inhibited platelet adhesion varied between experiments. The platelets obtained from individual donors are likely to vary both
in expression of Ligand Binding to Isolated Binding of Recombinant Ca2+Restores EGTA-inhibited
In conclusion, we have demonstrated an essential requirement for
micromolar concentrations of Ca2+ in
Mg2+-dependent
*
This work was supported in part by the Medical Research
Council of the United Kingdom.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Supported by a British Heart Foundation of the United Kingdom PhD
Studentship. To whom correspondence should be addressed: Tel.:
44-1223-333643; Fax: 44-1223-333345; E-mail: djo21@hermes.cam. ac.uk.
Published, JBC Papers in Press, May 25, 2000, DOI 10.1074/jbc.M004111200
2
Protected by International Patent Application
PCT/GB99/00992.
3
L. F. Morton (this laboratory), unpublished observations.
4
E. M. Wijnen (this laboratory), unpublished observations.
5
Determined by flow cytometry (M. Makris,
unpublished observation).
The abbreviations used are:
MIDAS, metal
ion-dependent adhesion site;
BSA, bovine serum albumin;
CRP, collagen-related peptide;
GST, glutathione
S-transferase.
Micromolar Ca2+ Concentrations Are Essential for
Mg2+-dependent Binding of Collagen by the
Integrin
2
1 in Human Platelets*
§,
,
, and
Department of Biochemistry, University of
Cambridge, Building 0, Downing Site, Cambridge CB2 1QW, United
Kingdom and the ¶ School of Biological Sciences, University of
Manchester, Oxford Road, Manchester M13 9PT, United Kingdom
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
2
1 requires micromolar
Ca2+ to bind to collagen and to the peptide
GPC(GPP)5GFOGER(GPP)5GPC (denoted
GFOGER-GPP, where O represents hydroxyproline), which contains the
minimum recognition sequence for the collagen-binding
2
I-domain (Knight, C. G., Morton, L. F., Peachey, A. R.,
Tuckwell, D. S., Farndale, R. W., and Barnes, M. J. (2000) J. Biol. Chem. 275, 35-40). Platelet adhesion
to these ligands is completely dependent on
2
1 in the presence of 2 mM
Mg2+. However, we show here that this interaction was
abolished in the presence of 25 µM EGTA. Adhesion of
Glanzmann's thrombasthenic platelets, which lack the fibrinogen
receptor
IIb
3, was also inhibited by
micromolar EGTA. Mg2+-dependent adhesion of
platelets was restored by the addition of 10 µM
Ca2+, but millimolar Ca2+ was inhibitory.
Binding of isolated
2
1 to GFOGER-GPP was
70% inhibited by 50 µM EGTA but, as with intact
platelets, was fully restored by the addition of micromolar
Ca2+. 2 mM Ca2+ did not inhibit
binding of isolated
2
1 to collagen or to
GFOGER-GPP. Binding of recombinant
2 I-domain was not
inhibited by EGTA, nor did millimolar Ca2+ inhibit binding.
Our data suggest that high affinity Ca2+ binding to
2
1, outside the I-domain, is essential
for adhesion to collagen. This is the first demonstration of a
Ca2+ requirement in
2
1 function.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
and a
subunit (1).
The N-terminal region of the
subunits has been modeled as a
seven-bladed
-propeller (2), containing EF-hand-like cation-binding
motifs (3). Nine
subunits, including
1 and
2, contain an inserted domain (I-domain) of ~200 amino
acids, homologous to the von Willebrand Factor A-domain, located
between blades 2 and 3 of the proposed
-propeller structure (4). The isolated I-domain of
2 is capable of ligand binding
(4-6). The I-domain within
2
1 is crucial
for collagen binding of the entire integrin. I-domain crystal
structures reveal the presence of a single metal
ion-dependent adhesion site
(MIDAS)1 (7-9), which is
thought to be occupied by Mg2+ in vivo.
2
1 is a collagen
receptor that plays an important role in hemostasis. Injury to the
endothelium of a blood vessel results in the exposure of collagen
fibers to circulating platelets, resulting in their adhesion and
activation, leading to platelet aggregation and clot formation (10,
11). Integrin
2
1 is essential for the
recognition of collagen by platelets under flow conditions (10, 12) and
platelets lacking functional integrin
2
1
do not respond to stimulation by collagen (13), resulting in bleeding
disorders. The sequence
GFOGER,2 within a
triple-helical structure, was recently identified as the minimum
binding motif within collagen I for
1 and
2 I-domains (14) and has been co-crystallized with the
2 I-domain, verifying its interaction with the
2 MIDAS (15). The availability of this peptide allows
the properties of
2
1 to be resolved from those of other, non-integrin, platelet receptors for collagen (11,
16).

heterodimeric structure of the platelet fibrinogen receptor,
IIb
3 (21), which is necessary for ligand
binding (22). In addition, fibrinogen binding to
IIb
3 is supported by millimolar levels of
either Ca2+ or Mg2+ (23). In marked contrast,
millimolar Ca2+ inhibits
Mg2+-dependent ligand binding of
2
1 (24, 25). Together, this evidence
suggests that Ca2+ has a crucial role in integrin function.
2
1, and of recombinant
2
I-domain to immobilized type I collagen and to the peptide GFOGER-GPP.
We demonstrate a requirement for micromolar Ca2+ in
2
1-mediated platelet adhesion and the
binding of isolated
2
1 to these
substrates. Both the stimulatory and inhibitory Ca2+-binding sites appear to lie outside the I-domain.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
IIb
3 were prepared from
whole blood, kindly provided by Dr. M. Makris (Royal Hallamshire
Hospital, Sheffield, UK), from two type I Glanzmann's patients.
Monomeric type I collagen for use in solid phase adhesion assays was
purified from bovine skin, following limited pepsin digestion, as
described previously (26, 27). The anti-(human integrin
2 subunit) monoclonal antibody 6F1 (28) was a generous
gift from Dr. B. S. Coller (Mount Sinai Hospital, New York,
NY). GR144053F was a gift from Glaxo Wellcome (Stevenage,
Hertfordshire, UK). Chemicals were from Sigma-Aldrich (Poole, Dorset,
UK) unless otherwise stated. Recombinant
2 I-domain, as
a glutathione S-transferase (GST) fusion protein, was
produced (5, 29) and used in solid phase binding assays as described previously (5, 29-31). Peptide
GPC(GPP)5GFOGER(GPP)5GPC (denoted GFOGER-GPP)
and collagen-related peptide (CRP; GCO(GPO)10GCOG) were
synthesized as described previously (14, 30, 31). The central GFOGER
sequence is the minimum recognition sequence for the
2
I-domain (14) and the flanking GPP sequences stabilize the
triple-helical conformation, which is essential for recognition (14,
26). Integrin
2
1 was purified from
solubilized membranes of human platelets by affinity chromatography on
collagen-Sepharose (32, 33), biotinylated using an Amersham Pharmacia
Biotech ECL biotinylation module, according to the manufacturer's
instructions. Purity of the preparation was assessed by separation on
SDS-polyacrylamide gel electrophoresis, followed by staining with
Gelcode blue stain reagent (Pierce and Warriner, Chester, UK) and image
analysis with Leica Q500 (34).
2
1 and
2
I-domain Binding Assay--
The assays for
2
1 (31, 32) and
2 I-domain
(5, 29) adhesion have been described previously. Briefly, 96-well
plates (Immulon 2) were coated and blocked as above. After three
washes with 200 µl of adhesion buffer, 100 µl of either
biotinylated
2
1 (1 µg/ml) or
recombinant GST-
2 I-domain fusion protein (5 µg/ml)
(both in adhesion buffer containing 2 mM MgCl2
and other ions as required), was applied to the wells and
incubated for 2 h at room temperature. Wells were then
washed as above and incubated for 30 min with 100 µl of either
0.67 µg/ml streptavidin-horseradish peroxidase (Pierce and
Warriner), for
2
1 detection, or 22 µg/ml rabbit anti-GST (Ig-peroxidase conjugate), for
2
I-domain detection. The wells were washed four times, and bound ligand
was detected using a 3,3',5,5'-tetramethylbenzidine-peroxidase
substrate system (Pierce and Warriner). Absorbance at 450 nm was
measured using a Maxline Emax plate reader. Results were corrected for
background as above and are scaled to an absorbance reading of 1 for collagen.
![]()
RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
2
1 Is
Calcium-dependent--
We first demonstrate the linearity
of the assay used to measure platelet adhesion (Fig.
1) and are in agreement with Bellavite and coworkers (35) that the relationship between absorbance at 405 nm
and platelet number is linear, in our conditions up to
A405 = 3.0. Platelet adhesion to monomeric
bovine type I collagen and to the peptide GFOGER-GPP requires the
presence of Mg2+ (14, 24, 25), although other divalent
cations such as Co2+ and Mn2+, but not
Ca2+, can replace Mg2+ in
2
1 binding (24) and
2
I-domain binding.3 Previous
work (5, 24, 25) suggests that Ca2+ inhibits
Mg2+-dependent adhesion. However, we found that
micromolar concentrations of EGTA, a Ca2+ chelator, blocked
platelet adhesion to collagen and to GFOGER-GPP in the presence of 2 mM Mg2+ (Fig. 2).
Platelet adhesion to collagen-related peptide (CRP), which is mediated
by the receptor glycoprotein VI in a cation-independent manner (37),
was unaffected by EGTA (data not shown).

View larger version (10K):
[in a new window]
Fig. 1.
Platelet number is directly proportional to
A405 nm. Platelets were loaded into
96-well plates and lysed for 1 h, and the absorbance of the
p-nitrophenol product was read at 405 nm, as described under
"Experimental Procedures." Data are from a single experiment,
representative of five identical experiments using platelets from
different donors and expressed as the mean of triplicate readings ± S.D. Where error bars are absent, they were too small to
be reproduced.

View larger version (18K):
[in a new window]
Fig. 2.
EGTA inhibits platelet adhesion to collagen
and to GFOGER-GPP. Platelets were preincubated with EGTA for 20 min in the presence of 2 mM MgCl2 and allowed
to adhere to wells coated with monomeric bovine type I collagen or
GFOGER-GPP as described under "Experimental Procedures." Data are
from a single experiment, representative of three identical
experiments using platelets from different donors and expressed as the
mean of triplicate readings ± S.D., scaled to an
A405 = 1 for adhesion to collagen in the
presence of 2 mM Mg2+ alone. Where
error bars are absent, they were too small to be
reproduced.
IIb
3,4
adhesion to either monomeric collagen I or to GFOGER-GPP was inhibited
(Fig. 3). One explanation for the
involvement of
IIb
3 might be that
platelet microaggregates form on the initial layer of adherent
platelets. Alternatively, the adhesion might involve indirect binding
of platelets to substrate in an
IIb
3-dependent manner, as has
been proposed previously (26, 28). We and others (14, 26, 28) have
shown that this component of adhesion is secondary to the initial
2
1-dependent adhesive
process, being entirely inhibited by 6F1 (Fig. 3).

View larger version (21K):
[in a new window]
Fig. 3.
EGTA inhibition of platelet adhesion to
collagen and to GFOGER-GPP is independent of integrin
IIb
3. Normal platelets were
preincubated for 20 min with 25 µM EGTA and 2 µM GR144053F individually or in combination, or with
anti-(human
2 integrin) monoclonal antibody 6F1 at 2 µg/ml. Platelets from type I Glanzmann's patients, lacking the
IIb
3 receptor, were preincubated for 20 min with 25 µM EGTA or 2 µM GR144053F. All
adhesions were performed in the presence of 2 mM
MgCl2. Data for normal platelets are from a single
experiment, representative of four identical experiments using
platelets from different donors and expressed as the mean of triplicate
readings ± S.D. Data for Glanzmann platelets are from a single
experiment, representative of two identical experiments from two donors
and expressed as the mean of triplicate readings ± S.D. Adhesion
of both the normal and Glanzmann platelets are scaled to an
A405 = 1 for adhesion of normal platelets to
collagen in the presence of 2 mM Mg2+ alone.
nd denotes "not done," and where error bars
are absent, they were too small to be reproduced.
IIb
3, the degree of inhibition of
adhesion induced by GR144053F would be the same as for EGTA alone and
no additional inhibition of adhesion would occur in the presence of
both of these substances. However, the left-hand side of Fig. 3
demonstrates that this is not the case; with normal platelets,
2 µM GR144053F resulted in ~50% inhibition of
adhesion to collagen I and ~70% inhibition of adhesion to
GFOGER-GPP, whereas 25 µM EGTA reduced adhesion to about
a quarter of these values. The effect of EGTA was greater than that of
GR144053F for adhesion to both collagen and to GFOGER-GPP (p < 0.001, analysis of variance). Therefore, blockade
of normal platelet adhesion by EGTA cannot be attributed solely to
inhibition of
IIb
3 but must include
inhibition of binding through
2
1. We do
not understand why GR144053F differentially inhibits platelet adhesion
to collagen I and GFOGER-GPP.
2 subunit, 6F1, completely abrogated platelet adhesion to either collagen or to GFOGER-GPP (Fig. 3), thus demonstrating the
absolute requirement of this receptor for adhesion to these ligands. In
control experiments (Fig. 3), 6F1 did not block adhesion of platelets
to CRP (37). These observations suggest that the inhibition of normal
platelet adhesion by EGTA in excess of that caused by GR144053F is due
to direct action on
2
1.
IIb
3, we examined adhesion using
platelets lacking the
IIb
3
receptor,5 from two Type I
Glanzmann's patients (Fig. 3, right-hand side). Adhesion of
these platelets to collagen I and to the
2
1-specific GFOGER-GPP was 80% inhibited
by micromolar EGTA (Fig. 3) but was completely insensitive to
GR144053F, validating the specificity of GR144053F for
IIb
3. The data in Fig. 3 show that the
EGTA-induced inhibition of platelet adhesion occurs in the absence of
IIb
3, supporting the concept that the
inhibition occurs at the level of
2
1.

View larger version (18K):
[in a new window]
Fig. 4.
Ca2+ restores EGTA-inhibited
platelet adhesion to collagen and to GFOGER-GPP. Platelets were
preincubated with 25 µM EGTA and the concentrations of
CaCl2 shown, in the presence of 2 mM
MgCl2, before allowing adhesion to ligand-coated wells.
Each point is scaled to an absorbance reading of 1 for adhesion to
collagen in the presence of 2 mM MgCl2 alone,
and under these conditions, adhesion to GFOGER-GPP gave an absorbance
of 0.9. Note: the x axis is non-linear. Data are from a
single experiment, representative of three identical experiments using
platelets from different donors and expressed as the mean of triplicate
readings ± S.D. Where error bars are absent, they were
too small to be reproduced.
2
1 and in sensitivity to
activation, so that they may secrete their granule load of
Ca2+ to different extents. However, it is important to note
that Ca2+ concentrations of around 100-200 nM
can restore EGTA-inhibited, Mg2+-dependent
platelet adhesion via the
2
1 receptor.
This suggests that Ca2+ binds at high affinity site(s) on
the platelet surface. The location of these sites may be either on
2
1 itself or on other surface proteins
that interact with
2
1 and modify its
binding affinity.
2
1 Shows
Partial Ca2+ Dependence--
The purity of the
2
1 preparation used in these assays was
judged to be ~90% by densitometric analysis of the polyacrylamide gel shown in Fig. 5. As with platelets,
binding of purified
2
1 to collagen and to
GFOGER-containing peptides is completely abolished by 6F1 (14, 30) and
is also inhibited by increasing concentration of EGTA (Fig.
6A). At 2 mM EGTA,
there is very little further inhibition of adhesion (data not shown).
Eleven repeat experiments found that in the presence of 50 µM EGTA,
2
1 binding to
GFOGER-GPP is reduced to 30 ± 3% but adhesion to collagen is
only reduced to 66 ± 4% (mean ± S.E.), perhaps because
2
1 binds to collagen sequences other than
GFOGER in a Ca2+-independent manner. It is possible that,
when removed from its proper membrane context, the unconstrained
integrin displays novel collagen binding activity in regions other than
its I-domain. It has also been speculated that integrin
subunits
may contain I-domain-like elements (7, 38), and it is possible that
1 adheres to sites other than GFOGER within collagen.
However, use of monoclonal antibodies directed against the
1 subunit did not result in significant blockade of
binding (data not shown). Others have found that recombinant
constructs, including
2 sequence up to the end of the
first EF-hand as well as the I-domain show enhanced capacity to bind
collagen (4), although the mechanism is unclear. These regions of
2 may either increase the affinity of the MIDAS or bind
to collagen at a site distinct from GFOGER. However, it is clear that
adhesion of isolated
2
1 to the
2 I-domain-specific peptide, GFOGER-GPP, is highly
sensitive to EGTA, suggesting that Ca2+ has a role in
affinity regulation of the I-domain.

View larger version (91K):
[in a new window]
Fig. 5.
2
1
preparation is at least 90% pure. 9 µg of
2
1 preparation was separated by
SDS-polyacrylamide gel electrophoresis on a 6% gel.

View larger version (20K):
[in a new window]
Fig. 6.
EGTA inhibits
2
1
adhesion to collagen and to GFOGER-GPP, but adhesion of
2 I-domain to these ligands is
insensitive to EGTA or Ca2+. A,
biotinylated
2
1 was preincubated with
EGTA for 15 min, before measuring adhesion. B, recombinant
GST-
2 I-domain fusion protein was preincubated with EGTA
or CaCl2 for 15 min before measuring adhesion. All
adhesions were performed in the presence of 2 mM
MgCl2. Data are from a single experiment, representative of
three identical experiments and expressed as the mean of triplicate
readings ± S.D., scaled to an A450 = 1 for
adhesion to collagen in the presence of 2 mM
Mg2+ alone. Where error bars are absent, they
were too small to be reproduced.
2 I-domain Is
Ca2+-independent--
By marked contrast, binding of
recombinant GST-
2 I-domain fusion protein to
collagen and to GFOGER-GPP was completely unaffected by EGTA, even up
to 2 mM levels (Fig. 6B). In
addition, up to 10 mM Ca2+ had no significant
effect on adhesion of the I-domain to these ligands. The insensitivity
to EGTA suggests that the activatory Ca2+ binding site is
not found within the I-domain and must lie elsewhere within
2
1. Also, the well-documented inhibitory
effect of Ca2+ on
2
1-mediated
adhesion (24, 25) cannot be due to direct competition for the
Mg2+ ion bound at the MIDAS site within the I-domain, which
is in agreement with others (4).
2
1 Binding--
The EGTA-induced
inhibition of isolated
2
1 adhesion can be
restored by the addition of Ca2+ (Fig.
7). A 60% reduction in
2
1 binding to GFOGER-GPP was observed in
the presence of 50 µM EGTA, which could subsequently be
restored by addition of Ca2+. A similar pattern was
observed for binding to collagen. Recovery of adhesion corresponds to
estimated free Ca2+ concentrations in the range of 2-50
µM (36). The rescue of adhesion observed here is similar
to that observed with whole platelets, but a striking difference is
that 2 mM Ca2+ does not significantly inhibit
adhesion of integrin
2
1 to its ligands.
In fact, the presence of 10 mM Ca2+ results in
only partial reduction of adhesion to either collagen I or to
GFOGER-GPP (Fig. 7), suggesting that the inhibitory
Ca2+-binding site is either not present or non-functional
in the isolated integrin. Alternatively, millimolar Ca2+
might bind other cell surface proteins, which then regulate
2
1 ligand-binding affinity.

View larger version (32K):
[in a new window]
Fig. 7.
The EGTA-induced inhibition of
2
1
adhesion to collagen or to GFOGER-GPP can be restored by addition of
Ca2+. Biotinylated
2
1
was preincubated for 15 min with the concentrations of
CaCl2 shown and EGTA in the presence of 2 mM
MgCl2, before application to the ligand-coated wells. Data
are from a single experiment, representative of three identical
experiments and expressed as the mean of triplicate readings ± S.D.,
scaled to an A450 = 1 for adhesion to collagen
in the presence of 2 mM Mg2+ alone. Where
error bars are absent, they were too small to be
reproduced.
2
1-mediated platelet adhesion. Adhesion
of purified
2
1 to GFOGER-GPP was
significantly Ca2+-dependent, whereas, adhesion
to collagen had a large Ca2+-independent component. The
stimulatory Ca2+ binding site(s) is not situated within the
I-domain and, in agreement with others, Ca2+-mediated
inhibition of
2
1 adhesion does not act by
competition with the Mg2+ ion at the MIDAS (4). These
findings contribute to the understanding of the role of cations in the
regulation of
2
1 function.
![]()
FOOTNOTES
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
1.
Kühn, K.,
and Eble, J.
(1994)
Trends Cell Biol.
4,
256-261
2.
Springer, T. A.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
65-72
3.
Oxvig, C.,
and Springer, T. A.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
4870-4875
4.
Dickeson, S. K.,
Walsh, J. J.,
and Santoro, S. A.
(1997)
J. Biol. Chem.
272,
7661-7668
5.
Tuckwell, D.,
Calderwood, D. A.,
Green, L. J.,
and Humphries, M. J.
(1995)
J. Cell Sci.
108,
1629-1637
6.
Dickeson, S. K.,
Bhattacharyya-Pakrasi, M.,
Mathis, N. L.,
Schlesinger, P. H.,
and Santoro, S. A.
(1998)
Biochemistry
37,
11280-11288
7.
Lee, J. O.,
Rieu, P.,
Arnaout, M. A.,
and Liddington, R.
(1995)
Cell
80,
631-638
8.
Nolte, M.,
Pepinsky, R. B.,
Venyaminov, S. Y.,
Koteliansky, V.,
Gotwals, P. J.,
and Karpusas, M.
(1999)
FEBS Lett.
452,
379-385
9.
Emsley, J.,
King, S. L.,
Bergelson, J. M.,
and Liddington, R. C.
(1997)
J. Biol. Chem.
272,
28512-28517
10.
Sixma, J. J.,
van Zanten, G. H.,
Huizinga, E. G.,
van der Plas, R. M.,
Verkleij, M.,
Wu, Y.-P.,
Gros, P.,
and de Groot, P. G.
(1997)
Thromb. Haemostasis
78,
434-438
11.
Moroi, M.,
and Jung, S. M.
(1997)
Thromb. Haemostasis
78,
439-444
12.
Verkleij, M. W.,
Morton, L. F.,
Knight, C. G.,
de Groot, P. G.,
Barnes, M. J.,
and Sixma, J. J.
(1998)
Blood
91,
3808-3816
13.
Nieuwenhuis, H. K.,
Akkerman, J. W. N.,
Houdijk, W. P. M.,
and Sixma, J. J.
(1985)
Nature
318,
470-472
14.
Knight, C. G.,
Morton, L. F.,
Peachey, A. R.,
Tuckwell, D. S.,
Farndale, R. W.,
and Barnes, M. J.
(2000)
J. Biol. Chem.
275,
35-40
15.
Emsley, J.,
Knight, C. G.,
Farndale, R. W.,
Barnes, M. J.,
and Liddington, R. C.
(2000)
Cell
100,
47-56
16.
Kehrel, B.,
Wierwille, S.,
Clemetson, K. J.,
Anders, O.,
Steiner, M.,
Knight, C. G.,
Farndale, R. W.,
Okuma, M.,
and Barnes, M. J.
(1998)
Blood
91,
491-499
17.
Hu, D. D.,
Hoyer, J. R.,
and Smith, J. W.
(1995)
J. Biol. Chem.
270,
9917-9925
18.
Hu, D. D.,
Barbas, C. F., III,
and Smith, J. W.
(1996)
J. Biol. Chem.
271,
21745-21751
19.
Mould, A. P.,
Akiyama, S. K.,
and Humphries, M. J.
(1995)
J. Biol. Chem.
270,
26270-26277
20.
Pelletier, A. J.,
Kunicki, T.,
and Quaranta, V.
(1996)
J. Biol. Chem.
271,
1364-1370
21.
Fujimura, K.,
and Phillips, D. R.
(1983)
J. Biol. Chem.
258,
10247-10252
22.
Shattil, S. J.,
Motulsky, H. J.,
Insel, P. A.,
Flaherty, L.,
and Brass, L. F.
(1986)
Blood
68,
1224-1231
23.
Phillips, D. R.,
and Baughan, A. K.
(1983)
J. Biol. Chem.
258,
10240-10246
24.
Santoro, S. A.
(1986)
Cell
46,
913-920
25.
Staatz, W. D.,
Rajpara, S. M.,
Wayner, E. A.,
Carter, W. G.,
and Santoro, S. A.
(1989)
J. Cell Biol.
108,
1917-1924
26.
Morton, L. F.,
Peachey, A. R.,
Zijenah, L. S.,
Goodall, A. H.,
Humphries, M. J.,
and Barnes, M. J.
(1994)
Biochem. J.
299,
791-797
27.
Morton, L. F.,
Fitzsimmons, C. M.,
Rauterberg, J.,
and Barnes, M. J.
(1987)
Biochem. J.
248,
483-487
28.
Coller, B. S.,
Beer, J. H.,
Scudder, L. E.,
and Steinberg, M. H.
(1989)
Blood
74,
182-192
29.
Calderwood, D. A.,
Tuckwell, D. S.,
Eble, J.,
Kuhn, K.,
and Humphries, M. J.
(1997)
J. Biol. Chem.
272,
12311-12317
30.
Knight, C. G.,
Morton, L. F.,
Onley, D. J.,
Peachey, A. R.,
Messent, A. J.,
Smethurst, P. A.,
Tuckwell, D. S.,
Farndale, R. W.,
and Barnes, M. J.
(1998)
J. Biol. Chem.
273,
33287-33294
31.
Knight, C. G.,
Morton, L. F.,
Onley, D. J.,
Peachey, A. R.,
Ichinohe, T.,
Okuma, M.,
Farndale, R. W.,
and Barnes, M. J.
(1999)
Cardiovasc. Res.
41,
450-457
32.
Kern, A.,
Eble, J.,
Golbik, R.,
and Kühn, K.
(1993)
Eur. J. Biochem.
215,
151-159
33.
Messent, A. J.,
Tuckwell, D. S.,
Knäuper, V.,
Humphries, M. J.,
Murphy, G.,
and Gavritovic, J.
(1998)
J. Cell Sci.
111,
1127-1135
34.
Hargreaves, P. G.,
Licking, E. F.,
Sargeant, P.,
Sage, S. O.,
Barnes, M. J.,
and Farndale, R. W.
(1994)
Thromb. Haemostasis
72,
634-642
35.
Bellavite, P.,
Andrioli, G.,
Guzzo, P.,
Ariliano, P.,
Chirumbolo, S.,
Manzato, F.,
and Santonastaso, C.
(1994)
Anal. Biochem.
216,
444-450
36.
Bers, D. M.,
Patton, C. W.,
and Nuccitelli, R.
(1994)
Methods Cell Biol.
40,
3-29
37.
Morton, L. F.,
Hargreaves, P. G.,
Farndale, R. W.,
Young, R. D.,
and Barnes, M. J.
(1995)
Biochem. J.
306,
337-344
38.
Tuckwell, D. S.,
and Humphries, M. J.
(1997)
FEBS Lett.
400,
297-303
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
A. Gigout, M. Jolicoeur, M. Nelea, N. Raynal, R. Farndale, and M. D. Buschmann Chondrocyte Aggregation in Suspension Culture Is GFOGER-GPP- and {beta}1 Integrin-dependent J. Biol. Chem., November 14, 2008; 283(46): 31522 - 31530. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Jarvis, N. Raynal, J. P. Langford, D. J. Onley, A. Andrews, P. A. Smethurst, and R. W. Farndale Identification of a major GpVI-binding locus in human type III collagen Blood, May 15, 2008; 111(10): 4986 - 4996. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Smethurst, D. J. Onley, G. E. Jarvis, M. N. O'Connor, C. G. Knight, A. B. Herr, W. H. Ouwehand, and R. W. Farndale Structural Basis for the Platelet-Collagen Interaction: THE SMALLEST MOTIF WITHIN COLLAGEN THAT RECOGNIZES AND ACTIVATES PLATELET GLYCOPROTEIN VI CONTAINS TWO GLYCINE-PROLINE-HYDROXYPROLINE TRIPLETS J. Biol. Chem., January 12, 2007; 282(2): 1296 - 1304. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Lisman, N. Raynal, D. Groeneveld, B. Maddox, A. R. Peachey, E. G. Huizinga, P. G. de Groot, and R. W. Farndale A single high-affinity binding site for von Willebrand factor in collagen III, identified using synthetic triple-helical peptides Blood, December 1, 2006; 108(12): 3753 - 3756. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Raynal, S. W. Hamaia, P. R.-M. Siljander, B. Maddox, A. R. Peachey, R. Fernandez, L. J. Foley, D. A. Slatter, G. E. Jarvis, and R. W. Farndale Use of Synthetic Peptides to Locate Novel Integrin {alpha}2beta1-binding Motifs in Human Collagen III J. Biol. Chem., February 17, 2006; 281(7): 3821 - 3831. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. O. Humtsoe, J. K. Kim, Y. Xu, D. R. Keene, M. Hook, S. Lukomski, and K. K. Wary A Streptococcal Collagen-like Protein Interacts with the {alpha}2{beta}1 Integrin and Induces Intracellular Signaling J. Biol. Chem., April 8, 2005; 280(14): 13848 - 13857. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R.-M. Siljander, S. Hamaia, A. R. Peachey, D. A. Slatter, P. A. Smethurst, W. H. Ouwehand, C. G. Knight, and R. W. Farndale Integrin Activation State Determines Selectivity for Novel Recognition Sites in Fibrillar Collagens J. Biol. Chem., November 12, 2004; 279(46): 47763 - 47772. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ajroud, T. Sugimori, W. H. Goldmann, D. M. Fathallah, J.-P. Xiong, and M. A. Arnaout Binding Affinity of Metal Ions to the CD11b A-domain Is Regulated by Integrin Activation and Ligands J. Biol. Chem., June 11, 2004; 279(24): 25483 - 25488. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R.-M. Siljander, I. C. A. Munnix, P. A. Smethurst, H. Deckmyn, T. Lindhout, W. H. Ouwehand, R. W. Farndale, and J. W. M. Heemskerk Platelet receptor interplay regulates collagen-induced thrombus formation in flowing human blood Blood, February 15, 2004; 103(4): 1333 - 1341. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lahav, E. M. Wijnen, O. Hess, S. W. Hamaia, D. Griffiths, M. Makris, C. G. Knight, D. W. Essex, and R. W. Farndale Enzymatically catalyzed disulfide exchange is required for platelet adhesion to collagen via integrin {alpha}2{beta}1 Blood, September 15, 2003; 102(6): 2085 - 2092. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Perret, J. A. Eble, P. R.-M. Siljander, C. Merle, R. W. Farndale, M. Theisen, and F. Ruggiero Prolyl Hydroxylation of Collagen Type I Is Required for Efficient Binding to Integrin {alpha}1{beta}1 and Platelet Glycoprotein VI but Not to {alpha}2{beta}1 J. Biol. Chem., August 8, 2003; 278(32): 29873 - 29879. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-M. Zhang, J. Kapyla, J. S. Puranen, C. G. Knight, C.-F. Tiger, O. T. Pentikainen, M. S. Johnson, R. W. Farndale, J. Heino, and D. Gullberg alpha 11beta 1 Integrin Recognizes the GFOGER Sequence in Interstitial Collagens J. Biol. Chem., February 21, 2003; 278(9): 7270 - 7277. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kamata, K. K. Tieu, T. Tarui, W. Puzon-McLaughlin, N. Hogg, and Y. Takada The Role of the CPNKEKEC Sequence in the {beta}2 Subunit I Domain in Regulation of Integrin {alpha}L{beta}2 (LFA-1) J. Immunol., March 1, 2002; 168(5): 2296 - 2301. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Nieswandt, V. Schulte, W. Bergmeier, R. Mokhtari-Nejad, K. Rackebrandt, J.-P. Cazenave, P. Ohlmann, C. Gachet, and H. Zirngibl Long-term Antithrombotic Protection by In Vivo Depletion of Platelet Glycoprotein VI in Mice J. Exp. Med., February 12, 2001; 193(4): 459 - 470. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Achison, C. M. Elton, P. G. Hargreaves, C. G. Knight, M. J. Barnes, and R. W. Farndale Integrin-independent Tyrosine Phosphorylation of p125fak in Human Platelets Stimulated by Collagen J. Biol. Chem., January 26, 2001; 276(5): 3167 - 3174. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. D. Arora, L. Silvestri, |